# Myeloproliferative Disorders studies recruiting: 30 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 30 trials that are observational for Myeloproliferative Disorders that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Myeloproliferative Disorders studies: 30 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/myeloproliferative-disorders

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 30
- Recruiting or not yet: 30
- Read on: November 19, 2026

## Trials

The 25 newest of 30, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 9, 2026 | NCT07925671 | Jaktinib in Ruxolitinib-Treatment Failure Myelofibrosis: A Multicenter, Prospective, Real-World Observational Study | Affiliated Hospital of Nantong University | Observational | Not yet recruiting | Myeloproliferative Neoplasms/Myelofibrosis | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07925671) |
| November 9, 2026 | NCT07925632 | A Multicenter, Prospective, Observational Study of Jaktinib in Newly Diagnosed Myelofibrosis | Affiliated Hospital of Nantong University | Observational | Not yet recruiting | Myeloproliferative Neoplasms/Myelofibrosis | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07925632) |
| September 22, 2026 | NCT07834918 | Pulmonary Hypertension and RV Dysfunction in Myeloproliferative Neoplasms | Assiut University | Observational | Not yet recruiting | Myeloproliferative Neoplasm, Right Ventricular Dysfunction, Pulmonary Hypertension | 145 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07834918) |
| September 22, 2026 | NCT07832513 | Study of Pregnancy in Patients With Myeloproliferative Neoplasms | University Health Network, Toronto | Observational | Not yet recruiting | Myeloproliferative Neoplasm (MPN), Pregnancy | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07832513) |
| July 2, 2026 | NCT07680868 | Caris Chromoseq Data Collection | Caris Science, Inc. | Observational | Recruiting | Acute Myeloid Leukemia (AML), Myelodysplastic (MDS) / Myeloproliferative (MPN) Diseases, Myelodysplatic Syndromes... | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07680868) |
| June 15, 2026 | NCT07648433 | Replacing Bone Marrow Diagnostics With Peripheral Blood Analysis in MPN Patients | Weizmann Institute of Science | Observational | Not yet recruiting | Myeloproliferative Neoplasm | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07648433) |
| May 15, 2026 | NCT07590986 | Identification of MPN-specific Antigens and Anti-MPN TCRs in Myeloproliferative Neoplasm | Université Catholique de Louvain | Observational | Recruiting | Myeloproliferative Neoplasm (MPN), Polycytemia Vera, Essential Thrombocythemia (ET), Primary Myelofibrosis (PMF) | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07590986) |
| January 23, 2026 | NCT07362225 | MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative... | MPN Research Foundation | Observational | Recruiting | Polycythemia Vera, ET (Essential Thrombocythemia), Polycythemia Vera (PV), Essential Thrombocythemia (ET), Primary... | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07362225) |
| October 2, 2025 | NCT07204392 | Unveiling the Germline Predisposition to Myeloproliferative Neoplasms | Fondazione IRCCS Policlinico San Matteo di Pavia | Observational | Recruiting | Myeloproliferative Disease, Germline Mutation | 313 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07204392) |
| August 6, 2025 | NCT07108023 | Hematological Disorders in EHPVO Patients | Sponsor not shown (see the record) | Observational | Not yet recruiting | Extrahepatic Portal Vein Obstruction (EHPVO), Thrombophilia, Myeloproliferative Neoplasms (MPN), Antiphospholipid... | 115 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07108023) |
| December 31, 2024 | NCT06753279 | Clinical Significance of Leukocyte Cell Population Data in Patients With Myeloproliferative Neoplasms (MPNs) | Assiut University | Observational | Not yet recruiting | Myeloproliferative Neoplasms (MPNs) | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06753279) |
| December 19, 2024 | NCT06743035 | Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic Splenomegaly | iOMEDICO AG | Observational | Recruiting | Polycythemia Vera | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06743035) |
| December 4, 2024 | NCT06715267 | Children, Adolescents and Young Adults with Myeloproliferative Neoplasia: Study of Clinico-biological Characteristics and Complications... | University Hospital, Brest | Observational | Recruiting | Myeloproliferative Neoplasm | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06715267) |
| June 28, 2024 | NCT06480591 | Evaluation of the Pathobiology of CALR-mutated MPN Cells | Wake Forest University Health Sciences | Observational | Recruiting | Myeloproliferative Neoplasm | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06480591) |
| June 17, 2024 | NCT06462664 | Exploring the Impact of Monocytes in Myeloproliferative Neoplasia (EMYNEM) | University Hospital, Brest | Observational | Recruiting | Myeloproliferative Neoplasm | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06462664) |
| March 28, 2024 | NCT06334913 | A Prospective Patient Reported Outcomes and Wearables Study in Myeloproliferative Neoplasms | Guy's and St Thomas' NHS Foundation Trust | Observational | Not yet recruiting | Myeloproliferative Neoplasm | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06334913) |
| November 14, 2023 | NCT06131801 | Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution | Children's Hospital Medical Center, Cincinnati | Observational | Recruiting | Hematologic Malignancy, Leukemia, Lymphoma, Acute Lymphocytic Leukemia, ALL, Acute Myelogenous Leukemia, AML, Chronic... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06131801) |
| September 1, 2023 | NCT06022328 | Impact of Epigenetic Age on Clinic-biological Presentation and Prognosis in Myeloproliferative Neoplasms Epigenetic Age in... | University Hospital, Bordeaux | Observational | Recruiting | Myeloproliferative Neoplasm | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06022328) |
| August 1, 2023 | NCT05969821 | Clonal Hematopoiesis of Immunological Significance | Assistance Publique - Hôpitaux de Paris | Observational | Not yet recruiting | Immune System Diseases, Autoimmune Diseases, Inflammation, Autoinflammatory Diseases, Vexas Syndrome, Hematopoiesis... | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05969821) |
| May 31, 2023 | NCT05882773 | Asian Myeloproliferative Neoplasm (MPN) Registry | The University of Hong Kong | Observational | Recruiting | Myeloproliferative Neoplasm, Polycythemia Vera, Essential Thrombocythemia, Post-polycythemia Vera Myelofibrosis... | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05882773) |
| May 9, 2023 | NCT05850273 | Mechanism of Action of Interferon in the Treatment of Myeloproliferative Neoplasms | Institut National de la Santé Et de la Recherche Médicale, France | Observational | Recruiting | Myeloproliferative Neoplasm | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05850273) |
| May 3, 2023 | NCT05839717 | Determination of the Clonality Profile in Myeloproliferative Neoplasms and Association With the Thrombotic Complications (CLOJAK) | University Hospital, Bordeaux | Observational | Recruiting | Myeloproliferative Neoplasm | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05839717) |
| September 23, 2022 | NCT05553873 | Evaluation of Inflammatory Markers in ph Negative Myeloproliferative Neoplasms: Impact on Outcome and Response to Therapy. Multicenter... | University of Milano Bicocca | Observational | Recruiting | Myeloproliferative Disease, Inflammatory Markers | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05553873) |
| July 1, 2022 | NCT05440838 | Identification of Factors Associated With Treatment Response in Patients With Polycythemia Vera, Essential Thrombocythemia, and... | University Hospital, Angers | Observational | Recruiting | Myeloproliferative Neoplasm | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05440838) |
| April 14, 2022 | NCT05326919 | The Patient Cohort of the National Center for Precision Medicine in Leukemia | Assistance Publique - Hôpitaux de Paris | Observational | Recruiting | Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, High-risk Myelodysplastic Syndrome, Secondary Myelofibrosis in... | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05326919) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University Hospital, Brest | 2 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Assiut University | 2 |
| University Hospital, Bordeaux | 2 |
| University Health Network, Toronto | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| Affiliated Hospital of Nantong University | 2 |
| Wake Forest University Health Sciences | 1 |
| Caris Science, Inc. | 1 |
| MPN Research Foundation | 1 |
| Guy's and St Thomas' NHS Foundation Trust | 1 |
| The University of Hong Kong | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| Children's Oncology Group | 1 |
| Massive Bio, Inc. | 1 |
| Weizmann Institute of Science | 1 |
| [iOMEDICO AG](https://specstream.ai/data/clinical-trials/company/iomedico-ag) | 1 |
| Fondazione IRCCS Policlinico San Matteo di Pavia | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Université Catholique de Louvain | 1 |
| University of Milano Bicocca | 1 |
| University Hospital, Angers | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 8 |
| France | 8 |
| Canada | 2 |
| Puerto Rico | 2 |
| China | 2 |
| Italy | 2 |
| Hong Kong | 1 |
| Australia | 1 |
| New Zealand | 1 |
| Saudi Arabia | 1 |
| Germany | 1 |
| Belgium | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Wholesale florists in the United States](https://specstream.ai/data/businesses/wholesale-florists/united-states)
- [Allergy and immunology practices in the United States](https://specstream.ai/data/businesses/allergy-and-immunology-practices/united-states)
- [Avionics shops in the United States](https://specstream.ai/data/businesses/avionics-shops/united-states)
- [B2B signage companies in the United States](https://specstream.ai/data/businesses/b2b-signage-companies/united-states)
- [Boat and ship manufacturers in the United States](https://specstream.ai/data/businesses/boat-and-ship-manufacturers/united-states)
- [Cardiology practices in the United States](https://specstream.ai/data/businesses/cardiology-practices/united-states)
